Coastal Research Associates, LLC

Roswell, Georgia 30076

2 studies enrolling now · 22 studies all time

What they study most

Dry Eye Disease, Glaucoma, Glaucoma Open-Angle Primary, Glaucoma, Open-Angle, Ocular Hypertension, Ocular Hypertension (OH), Ocular Hypertension (OHT), Ocular Inflammation and Pain, Open Angle Glaucoma, Open-Angle Ocular Hypertension, Open-angle Glaucoma, Ocular Hypertension, Primary Open Angle Glaucoma (POAG)

Studies at this site

• A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study — Recruiting now
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. — Recruiting now
• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension — Completed
• Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease — Completed
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease — Completed
• Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients — Completed
• Rocklatan® Evaluation — Completed
• Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery — Completed
• A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension — Completed
• A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study — Completed
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting — Completed
• Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension — Completed
• Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes — Completed
• Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure — Completed
• Study of AR-13324 in Patients With Elevated Intraocular Pressure — Completed
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure — Completed
• Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure — Completed
• AR-12286 in Combination With Latanoprost — Completed
• A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days — Completed
• A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma — Completed